Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi

suck pdf from helios

10.1111/jocs.14538

http://scihub22266oqcxt.onion/10.1111/jocs.14538
suck pdf from google scholar
32306491!7264604!32306491
unlimited free pdf from europmc32306491    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32306491  :  Publisher
PDF vom PMID32306491

suck abstract from ncbi

pmid32306491
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review #MMPMID32306491
  • Aghagoli G; Gallo Marin B; Soliman LB; Sellke FW
  • J Card Surg 2020[Jun]; 35 (6): 1302-1305 PMID32306491show ga
  • BACKGROUND: Respiratory complications have been well remarked in the novel coronavirus disease (SARS-CoV-2/COVID-19), yet an emerging body of research indicates that cardiac involvement may be implicated in poor outcomes for these patients. AIMS: This review seeks to gather and distill the existing body of literature that describes the cardiac implications of COVID-19. MATERIALS AND METHODS: The English literature was reviewed for papers dealing with the cardiac effects of COVID-19. RESULTS: Notably, COVID-19 patients with pre-existing cardiovascular disease are counted in greater frequency in intensive care unit settings, and ultimately suffer greater rates of mortality. Other studies have noted cardiac presentations for COVID-19, rather than respiratory, such as acute pericarditis and left ventricular dysfunction. In some patients there has been evidence of acute myocardial injury, with correspondingly increased serum troponin I levels. With regard to surgical interventions, there is a dearth of data describing myocardial protection during cardiac surgery for COVID-19 patients. Although some insights have been garnered in the study of cardiovascular diseases for these patients, these insights remain fragmented and have yet to cement clear guidelines for actionable clinical practice. CONCLUSION: While some information is available, further studies are imperative for a more cohesive understanding of the cardiac pathophysiology in COVID-19 patients to promote more informed treatment and, ultimately, better clinical outcomes.
  • |*Cause of Death[MESH]
  • |Betacoronavirus[MESH]
  • |COVID-19[MESH]
  • |Cardiovascular Diseases/diagnosis/*epidemiology[MESH]
  • |Comorbidity[MESH]
  • |Coronavirus Infections/diagnosis/*epidemiology[MESH]
  • |Disease Outbreaks/*statistics & numerical data[MESH]
  • |Female[MESH]
  • |Global Health[MESH]
  • |Humans[MESH]
  • |Male[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/diagnosis/*epidemiology[MESH]
  • |Prevalence[MESH]
  • |Risk Assessment[MESH]
  • |SARS-CoV-2[MESH]
  • |Severity of Illness Index[MESH]
  • |Survival Analysis[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    1302 6.35 2020